Fundraising Fox

NeuroPace

NASDAQ: NPCE

Mountain View, US · Founded 1999 · Delaware corporation · 245 employees on LinkedIn · 3 known investors

NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.

Digital HealthHardwareHealthtechMedical Devices

Founders & leadership

RKRebecca Kuhn
Rebecca KuhninSenior Strategic Advisor - Finance2025–2026
FF
Frank FischerExecutive
VB
Vince BurgessNamed on SEC filing
RR
Renee RyanNamed on SEC filing
RL
Ray LarkinNamed on SEC filing
GG
Greg GarfieldNamed on SEC filing
MF
Mike FavetNamed on SEC filing
NK
Nael KassarNamed on SEC filing

Board

JSJonathan Silverstein
Jonathan SilversteininBoard directorPartner at OrbiMed
JL
Joseph LacobBoard director

Investors · 3

Accelmed PartnersMiami
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
OrbiMedNew York · $1M – $75M

Reported raises · per SEC filings

Form D private placements

$141.4M disclosed across 2 rounds · 2016–2020

▶$69.4MraisedAug 2020 · 23 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Nael KassarDirector
  • Rebecca KuhnExecutive Officer
  • Mike FavetExecutive Officer, Director
  • Frank FischerExecutive Officer, Director
  • Greg GarfieldDirector
  • Renee RyanDirector
  • Rishi GuptaDirector
  • Vince BurgessDirector
  • Evan NortonDirector
  • Joseph LacobDirector
Offering amount
$96.4M
Amount sold
$69.4M
Finders' fees
$663.4K
First sale
Aug 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$72MraisedAug 2017 · 26 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Rebecca KuhnExecutive Officer
  • Vince BurgessDirector
  • Renee RyanDirector
  • Ray LarkinDirector
  • Jonathan SilversteinDirector
  • Frank FischerExecutive Officer, Director
  • Joseph LacobDirector
  • Greg GarfieldDirector
  • Mike FavetDirector
  • Nael KassarDirector
Offering amount
$80M
Amount sold
$72M
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through NeuroPace went on to found or lead other companies.

Patrick BeaulieuPrincipal EngineerFounded MurjBenjamin ShanahanResearch Software EngineerFounded Senra Systems

Competitors · 2

by search overlap
Practo1058 shared keywordsPracto operates an online healthcare platform offering a directory of verified doctors, appointment booking at hospitals and clinics, online consultations across 20+ specialities, subscription health plans, diagnostic test collection, and medicine delivery. It also provides practice management and hospital information management software for clinics and hospitals.
Vivian Health522 shared keywordsHealthTrust Workforce Solutions is a healthcare staffing and recruitment platform that connects clinical professionals with travel and local contract positions at hospitals and healthcare facilities nationwide. The company provides nurses, technologists, therapists, and other healthcare workers with access to job opportunities while supporting healthcare facilities with workforce solutions.

Companies competing with NeuroPace for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

NeuroPace to Join Cantor Healthcare Conference Sept. 9 | NPCE Stock Newsstocktitan.net · Sep 2026NeuroPace at Wells Fargo Healthcare Conference Sept. 8 | NPCE Stock Newsstocktitan.net · Aug 2026Is NeuroPace a Buy as Growth Improves but Valuation Stays Elevated? — TradingView Newstradingview.com · Aug 2026NeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue Guidancefinance.yahoo.com · Aug 2026NeuroPace Raises 2026 Revenue Guidance: $99.5M-$101.5M | NPCE Stock Newsstocktitan.net · Aug 2026NeuroPace Raises $67 Million Financing to Support Commercial Expansion of the RNS® System for Refractory Epilepsyneuropace.com · Aug 2020

Frequently asked questions

What does NeuroPace do?
NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.
Who are NeuroPace's investors?
NeuroPace's investors include Accelmed Partners, New Enterprise Associates (NEA), OrbiMed.
How much funding has NeuroPace raised?
NeuroPace has disclosed $141.4M raised across 2 rounds.
Where is NeuroPace headquartered?
NeuroPace is headquartered in Mountain View, US.